Research programme: psychiatric disorder therapeutics - NeuroProfile
Latest Information Update: 28 Sep 2020
Price :
$50 *
At a glance
- Originator NeuroProfile
- Class
- Mechanism of Action Neuron modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Depressive disorders; Schizophrenia
Most Recent Events
- 28 Sep 2020 No recent reports of development identified for research development in Depressive disorders in Germany
- 28 Sep 2020 No recent reports of development identified for research development in Schizophrenia in Germany
- 11 Aug 2016 Early research in Depressive disorders in Germany (unspecified route)